Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shengmai Liquid is an **oral liquid formulation** of a classic Traditional Chinese Medicine compound, historically known as Shengmai San. It is composed of three primary herbal ingredients: **Codonopsis pilosula**, **Ophiopogon japonicus**, and **Schisandra chinensis**[1][3][10]. Shengmai Liquid is used clinically for cardiovascular support, fatigue, and, more recently, for post-viral fatigue syndromes such as Long COVID fatigue[1][3][10]. Its mechanism of action is thought to involve **improving cardiac contractility**, likely via enhancement of calcium signaling in myocardial cells (including effects on L-type Ca(2+) channels, SR Ca(2+)-ATPase, and ryanodine receptors)[10]. The preparation is recognized for replenishing "Qi" and fluids, nourishing Yin, and supporting the function of the heart in the context of Traditional Chinese Medicine (TCM)[4][8][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shengmai Liquid.